UP!
| 2015-10-29 | Lower Price Target | Robert W. Baird | Neutral | $14.00 to $9.00 |
| 2015-10-29 | Lower Price Target | Cowen and Company | Market Perform | $15.00 to $10.00 |
| 2015-10-05 | Reiterated Rating | Morgan Stanley | Overweight | $7.00 to $9.00 |
| 2015-09-10 | Reiterated Rating | Sanford C. Bernstein | Market Perform | $15.00 |
| 2015-09-09 | Downgrade | Bank of America | Buy to Neutral | $16.00 to $13.00 |
| 2015-09-09 | Lower Price Target | Robert W. Baird | Neutral | $18.00 to $14.00 |
| 2015-05-06 | Downgrade | Cowen and Company | Outperform to Market Perform | $15.00 |
| 2015-02-19 | Boost Price Target | Bank of America | $17.00 | |
| 2014-12-02 | Downgrade | Leerink Swann | Outperform to Market Perform | $17.00 |
| 2014-08-14 | Downgrade | Robert W. Baird | Neutral to Underperform | |
| 2014-07-24 | Downgrade | Morgan Stanley | Buy to Neutral | $34.00 to $31.00 |
| 2014-07-24 | Downgrade | Bank of America | Buy to Neutral | $34.00 to $31.00 |
| 2014-07-21 | Downgrade | Stifel Nicolaus | Underweight | $12.00 to $7.00 |
| 2014-06-12 | Downgrade | Citigroup Inc. | Buy to Hold | |
| 2014-06-12 | Downgrade | Stifel Nicolaus | Buy to Hold | $37.86 |
| 2014-06-06 | Initiated Coverage | Bank of America | Buy | |
| 2014-06-02 | Downgrade | Robert W. Baird | Outperform to Neutral | $31.00 to $21.00 |
| 2014-05-07 | Reiterated Rating | Stifel Nicolaus | Buy | $52.00 to $47.00 |
| 2014-04-21 | Upgrade | Ned Davis Research | Sell to Neutral | |
| 2013-05-14 | Reiterated | Stifel | Buy | $44 to $54 |
| 2011-06-03 | Downgrade | Robert W. Baird | Outperform to Neutral | $30 to $23 |
| 2010-03-29 | Initiated | Piper Jaffray | Overweight | $16 |
| 2009-02-20 | Initiated | ThinkEquity | Buy | $23 |
| 2009-02-05 | Upgrade | Robert W. Baird | Neutral to Outperform | $15 to $23 |
| 2008-11-20 | Reiterated | Stanford Research | Buy | |
| 2008-09-05 | Initiated | Susquehanna Financial | Positive | |
| 2008-03-04 | Reiterated | Stanford Research | Buy | $34 to $26 |
| 2008-03-04 | Reiterated | Lehman Brothers | Equal-weight | $21 to $15 |
| 2007-10-26 | Upgrade | Stanford Research | Hold to Buy | $34 |
| 1970-01-01 |
| 2015-10-29 | Lower Price Target | Robert W. Baird | Neutral | $14.00 to $9.00 |
| 2015-10-29 | Lower Price Target | Cowen and Company | Market Perform | $15.00 to $10.00 |
| 2015-10-05 | Reiterated Rating | Morgan Stanley | Overweight | $7.00 to $9.00 |
| 2015-09-10 | Reiterated Rating | Sanford C. Bernstein | Market Perform | $15.00 |
| 2015-09-09 | Downgrade | Bank of America | Buy to Neutral | $16.00 to $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In THRX 182 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| ORBIMED ADVISORS LLC | 17.04M |
| BlackRock Fund Advisors | 8.36M |
| Sarissa Capital Management LP | 6.61M |
| PUTNAM INVESTMENTS LLC | 4.95M |
| FMR LLC | 4.80M |
| RENAISSANCE TECHNOLOGIES LLC | 4.27M |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3.96M |
| DIMENSIONAL FUND ADVISORS LP | 2.94M |
| LSV ASSET MANAGEMENT | 2.76M |
| BlackRock Institutional Trust Company, N.A. | 2.22M |
| Pacer Advisors, Inc. | 1.48M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.38M |
| GOLDMAN SACHS GROUP INC | 1.12M |
| D. E. Shaw & Co., Inc. | 0.93M |
| CITADEL ADVISORS LLC | 0.91M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| GLAXOSMITHKLINE PLC | 27.83% (32005260) | AGTC / CNCE / FOLD / GNCA / OMED / PATH / TBPH / THRX / |
| Aguiar Michael W Sr VP, Chief Financial Officer | 0.85% (980907) | THRX / |
| Winningham Rick E Chief Executive Officer | 0.72% (825391) | JAZZ / OMED / TBPH / THRX / |
| WHITESIDES GEORGE M | 0.53% (606377) | TBPH / THRX / |
| Shafer Bradford J Sr VP, Gen. Counsel, Secretary | 0.39% (443013) | TBPH / THRX / |
| BLUM LEONARD M Sr VP, Chief Comm. Officer | 0.35% (401538) | TBPH / THRX / |
| dEsparbes Eric SVP and CFO | 0.33% (384866) | THRX / |
| Mammen Mathai SVP, Research & Early Clin Dev | 0.29% (334040) | TBPH / THRX / |
| ABERCROMBIE GEORGE B Sr. VP, Corp. Partnerships | 0.27% (309917) | BCRX / OCRX / THRX / ZIOP / |
| Faerm Michael E. Sr VP & Chief Business Officer | 0.24% (279422) | THRX / |
| LEE JUNNING Sr. VP, Technical Operations | 0.23% (262198) | TBPH / THRX / |
| WITEK THEODORE L JR Sr. VP, Corp Partnerships | 0.23% (262017) | THRX / |
| WALTRIP WILLIAM H | 0.14% (161789) | THRX / |
| Gunderson Robert V JR | 0.10% (115970) | TBPH / THRX / VTAE / |
| LEVINE ARNOLD J | 0.10% (111794) | INFI / LIFE / THRX / |
| YOUNG WILLIAM D | 0.07% (83935) | BMRN / TBPH / THRX / VRTX / |
| PEPE PAUL | 0.06% (73805) | THRX / |
| FRIEDMAN CATHY | 0.06% (73805) | ETRM / RDUS / THRX / XNPT / YHOO / |
| Tyree James L | 0.06% (70554) | CCXI / DEPO / THRX / |
| LEPORE PATRICK G | 0.05% (58278) | PMC / THRX / |
| Duncan Barbara Gayle | 0.05% (52318) | ICPT / MDGN / THRX / |
| Brinkley David L Head of Business Dev. | 0.04% (48749) | PETX / THRX / |
| MALKIEL BURTON G | 0.03% (40000) | TBPH / THRX / |
| Kearney Terrence C | 0.03% (37083) | THRX / VRTX / XLRN / |
| Haimovitz Jules | 0.03% (36966) | ARIA / BCOR / THRX / |
| RINGROSE PETER S | 0.03% (36000) | RIGL / TBPH / THRX / |
| Fore Henrietta | 0.03% (33000) | GIS / TBPH / THRX / XOM / |
| Bickerstaff George | 0.03% (28762) | ARIA / CDNA / INO / THRX / |
| Kostas Odysseas D | 0.03% (28762) | MSTX / THRX / |
| DiPaolo Mark | 0.02% (24766) | THRX / |
| Schlesinger Sarah J. | 0.02% (24766) | ARIA / MDCO / THRX / |
| PASQUALONE FRANK Sr. Vice President, Operations | 0.02% (20000) | TBPH / THRX / |
| JONKER JEFFREY DAVID Senior VP, Corp. & Bus. Dev. | 0.01% (15000) | THRX / |
UM